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Abstract
Lymphatic filariasis is caused by filarial nematode parasites, including Brugia malayi. Adult worms live in the lymphatic
system and cause a strong immune reaction that leads to the obstruction of lymph vessels and swelling of the extremities.
Chronic disease leads to the painful and disfiguring condition known as elephantiasis. Current drug therapy is effective
against the microfilariae (larval stage) of the parasite, but no drugs are effective against the adult worms. One of the major
stumbling blocks toward developing effective macrofilaricides to kill the adult worms is the lack of a high throughput
screening method for candidate drugs. Current methods utilize systems that measure one well at a time and are time
consuming and often expensive. We have developed a low-cost and simple visual imaging system to automate and quantify
screening entire plates based on parasite movement. This system can be applied to the study of many macroparasites as
well as other macroscopic organisms.
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Introduction
Lymphatic filariasis is a devastating parasitic disease that affects
more than 120 million people in 81 countries [1]. Also known as
elephantiasis, the disease is caused by parasitic nematodes whose
adult forms inhabit the lymphatic system. WHO estimates that
over 1.3 billion people are at risk for lymphatic filariasis and
approximately 95% of infected individuals live in Africa and
South-East Asia.
Lymphatic filariasis is spread mainly by three species of
nematodes in the family Filariodidea: Wucheria bancrofi, Brugia
malayi and Brugia timori. The adult forms are threadlike round-
worms from 2–5 cm in length and adult females produce millions
of microfilariae that circulate in the blood where they are vectored
by mosquitoes. The microfilariae develop into the infectious form
in the mosquito and are inoculated into individuals when the
mosquito takes a blood meal. Larval forms migrate to the
lymphatic vessels and mature in 6–12 months and begin releasing
microfilariae, completing the cycle of transmission.
The WHO currently advocates interrupting transmission of the
disease via an annual mass drug administration of single doses of
albendazole and either diethylcarbamazine or ivermectin. These
drugs are effective at killing microfilariae but not effective against
adult worms (macrofilariae). Since adult worms can live for up to
6–8 years, treatment must be given on a regular basis to break the
cycle of transmission. This widespread treatment is logistically
challenging and costly, particularly in endemic regions that are
politically unstable. Such widespread application also raises the
threat of resistance, whose first signs are being seen with
ivermectin in Onchocerca volvulus [2]. Mass drug administration
would be greatly aided by a macrofilaricidal drug, as the adult
parasites would not be able to continue producing microfilariae for
the duration of the infection. Hence, there is a great need for new
macrofilaricidal drug candidates.
Currently there is no high throughput screening (HTS) method
available to screen compounds targeting any of these macroscopic
nematodes in vitro. Assays have been developed in recent years
that score worm migration, feeding and development [3–19] as
well as worm viability based on the MTT ((3-(4,5-dimethylthia-
zola-2-yl)-2, S-diphenyl tetrazolium bromide) assay [7,8,11–
13,20,21], but these are not amenable to screening 1000’s of
compounds with a quick turnaround time on large worms such as
filarid nematodes. Parasite movement is an important indication of
the effectiveness of a drug and constitutes a crucial phenotype for
HTS. Existing assays however, read only single wells at a time, are
low-throughput and are unaffordable for many laboratories in
developing nations [3,22–24]. In the context of analyzing the
phenotypes of model organisms, Buckingham and Sattelle
published an algorithm for measuring the thrashing of Caenorhab-
ditis elegans via a statistical analysis of the covariance matrix
between sets of frames to determine the period of thrashing [24].
The algorithm is specific to the thrashing phenotype and is not a
complete ready-to-screen software application. Both Buckingham
and Sattelle’s, and Ramot et al.’s [23] applications require that
individual videos be (manually) recorded of each well and then be
processed offline. Hence no affordance is made for automatically
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This makes their tools, as currently implemented, unsuitable for
use in a medium- or high-throughput assay. Smout et al. describes
an apparatus that does not use an optical assay but instead uses
special microtiter plates (xCELLigence and E-plate, Roche Inc.) to
measure movement [17]. Recently, efforts have been made for
screening Schistosoma spp. based on the quantification of multiple
phenotypic responses of the parasites to drugs (as opposed to
motility or a biochemical activity) [25]. However, these methods
are also not yet available as a ready-to-screen software application
or generalized to other macroparasites.
We have developed an inexpensive system (‘‘WormAssay’’) for
quantifying parasite movement based on worm motility. The
apparatus uses a commodity video camera, computer and a newly
developed free and open source software application to provide
quantitative measurements of parasite motility on entire plates.
The application can process multiple wells simultaneously without
user interaction, and automatically identifies each well in the plate
and labels the output data accordingly. This system can be used to
assay large parasites such as the filarid nematodes as well as other
macroparasites. WormAssay’s automation of the video capture
step and lack of need for any interaction with the computer
software during scoring differentiates it from all existing motion-
based schemes, and permits current screening of 400 worms per
assay each week.
Materials and Methods
Brugia malayi assays
Individual adult Brugia malayi female worms (TRS Labs Inc.,
Athens, GA) were assayed in RPMI-1640 (25 mM HEPES, 2 g/L
NaHCO3, Antibiotic/Antimycotic, 5% HI FBS) in 24-well tissue
culture plates (1 worm/well). 30 mM stock solutions of albenda-
zole (methyl 5-(propylthio)-2-benzimidazolecarbamate, Sigma),
ivermectin (22,23-dihydroavermectin B1, Sigma) and fenbenda-
zole (methyl 5-(phenylthio)-2-benzimidazolecarbamate, Sigma)
were prepared with DMSO (Sigma) and serially diluted in media
into concentrations of 300mM, 100mM, 30mM, 10mM, 3mM.
DMSO was used as the control and each concentration was run in
triplicate. Plates were maintained in a 370C5 %CO2 incubator for
48 hours. IC50 data were calculated using Microsoft Excel
(Microsoft Corp.) and Prism 5 (GraphPad Software, Inc.).
WormAssay computer program
The assays were performed using the open source computer
software program described here. This program is named
WormAssay. Plates were visualized using a Canon HV-40 Vixia
HDV camcorder (Canon Inc.) providing 1080p H.262/MPEG-2
Part 2 compressed HDV video connected via IEEE1384 to an
Apple iMac with a 2.93 GHz Intel Core i7 4-core CPU (Apple
Inc.) and WormAssay (version 0.15) for 1 minute. The application
and source code are available for free use, modification and
redistribution under the terms of the GNU Public License (version
2 or later; see http://www.gnu.org/licenses/gpl-2.0.html). The
application and its source code can be downloaded from http://
code.google.com/p/wormassay/.
Results
The WormAssay was developed for use in high throughput
screening of Brugia malayi adult female worms in 24-well plates.
Plates were screened using the visual imaging system (Figure 1 and
2) and software application to assess drug effects on adult female
Brugia malayi. One minute video recordings using the Lucas-Kande
Optical Flow algorithm (see Analysis Algorithms) were taken of
each plate and mean optical flow movement units for each worm
were converted to percent inhibition: w15 movement units=0%,
no inhibition (worms are very active); 10–15 movement
units=25%, slight inhibition (worms are active); 5–10 movement
units=50%, moderate inhibition (worms slightly moving); 2–5
movement units=75%, good inhibition (worms barely moving);
0–2 movement units=100%, very effective killing (worms are
dead), using Microsoft Excel and the CSV files generated by
WormAssay.
IC50 data for albendazole, ivermectin and fenbendazole were
calculated for each compound after 48 hours of incubation (see
Figure 3 and Videos S1, S2 and S3). Visual analysis of video
recordings and IC50 data indicate that ivermectin (IC50~2:7mM)
was the most effective in killing worms compared to albendazole
(IC50~236:2mM) and fenbendazole (IC50~54:5mM). After
48 hours, only control worms (1% DMSO only) were highly
active. In the ivermectin plate, only one of the 3 replicate worms
assayed in 3mM was found to be barely moving while the other 2
were not moving at all. Worms assayed with albendazole,
however, were found to be active even at 30mM. After 48 hours
of incubation at 300mM, one of the 3 worms exhibited activity
after 48 hours, while the second replicate was barely moving and
the third replicate was dead. Indeed, the IC50 of albendazole was
100-fold higher compared to that of ivermectin. Worms assayed
with fenbendazole at 300mM and 100mM were all dead but
worms in 30,10,3 and 0mM concentrations were found to be
active after 48 hours.
User interface
WormAssay’s data acquisition does not require user interaction
or configuration and is suitable for robotics integration with any
multi-degree-of-freedom plate manipulator. Data acquisition
automatically begins when a plate appears in the field of view
of the camera and data is written immediately upon removal of
the plate (Videos S4, S5 and S6). Video recordings of each read
Author Summary
The World Health Organization estimates that there are
approximately 37 million people who are afflicted by
Onchocerca volvulus (the parasitic worm that causes river
blindness) and over 120 million people afflicted by the
filarial worms Wuchereria and Brugia spp. (causative agents
of lymphatic filariasis or elephantiasis). Current mass drug
administration includes albendazole and either diethylcar-
bamazine or ivermectin. These drugs, however, are effective
at killing the early larval stage (microfilariae) released from
adult female worms but they do not kill the adult worms.
Adult worms can live up to 10 or more years, releasing
thousands of microfilariae perday.Itis essential therefore to
treat infected individuals with macrofilaricides in order to
prevent the adult parasites from producing microfiliariae for
the duration of the infection and to treat the disease. In
order to screen candidate drugs for use as macrofilaricides,
we have developed an inexpensive system and simple
method for quantifying the effectiveness of drugs on
parasite movement. The apparatus uses a commodity video
camera, a computer and a newly developed free and open
source software application to provide automated and
quantitative measurements of parasite motility on each
plate of worms. This system is not only useful for high
throughput screening of macroparasites but can also be
applied to the study of other macroscopic organisms as
well.
WormAssay: Parasite Motion Screening Application
www.plosntds.org 2 January 2012 | Volume 6 | Issue 1 | e1494are archived. Motility and other assay data are written to CSV
(spreadsheet style) files for use with standard statistical analysis
software tools. Barcode reading is performed on the video stream
(or from another video camera attached) to automatically label
results. The application can automatically email results at the end
of a run, for example, when used in a unattended automated
assay.
Plate tracking state machine
An extended finite state machine [26] is modeled programmat-
ically for each connected camera (see Figure 4). The finite state
machine describes the continuous analysis logic of WormAssay
that is used to automatically start recording data when a plate is
presented to the camera’s field of view. If more than one camera is
attached to the computer, only the first plate identified on a
camera is used for analysis. Other cameras are ignored until that
read is complete and the plate is removed from the field of view,
except for the purpose of plate identification, where all cameras
are inspected simultaneously for common barcode formats. This
allows one camera to be used for the motility assay and one or
more other cameras to be used for optional barcode recognition.
Any barcode text found is used to label the plate output in the
CSV files that are output containing the motility data.
Well finding
The application has no knowledge of the specific geometry of
the microtiter plates, except for the number of wells in each row
and column of the supported plate sizes. This allows for great
tolerance in terms of specific plate geometry and in the position of
the plate within the camera’s field of view. This is contrary to the
scheme used by most microtiter plate assay equipment, where a
mechanical sensor is positioned over or in the well of interest, one
well at a time.
The WormAssay well finding algorithm iterates through
acceptable plate configurations in parallel, corresponding to 6-,
12-, 24-, 48- and 96-well microtiter plates. First, Canny’s
algorithm [27] is used to find edge features. The Hough (circle)
transform [28] is used to find candidate wells efficiently among
these edge features. The search for appropriate circles is
performed efficiently by limiting the candidate circle size to
correspond to the expected range of sizes for a well, under the
assumption that the plate fills a simple majority of the imaging
field. The resulting circles are then filtered to only accept those
that lie on an axis-aligned collinear grid corresponding to the plate
row and column configuration. If all expected wells are then found
for the plate configuration, the algorithm deems the plate found
and moves the state machine down the found edge. If a plate is not
Figure 1. Dark field macroscopic imaging apparatus and computer application. The video camera is positioned below the microtiter plate
and the plate is recorded using the WormAssay software.
doi:10.1371/journal.pntd.0001494.g001
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the high-frequency components of the image. This makes it
possible for the Canny edge finding step of the Hough transform to
detect the edges that correspond to the well circles in out of focus
or poorly illuminated images. If a plate has already been detected,
future detection attempts only search for that plate configuration
(well count), to reduce CPU resource utilization. Finally, the
application uses the location of the wells to label each well
canonically (e.g. A1, B1, etc.) in both the real-time screen preview
(teal colored text in Figure 2b and 5b, also see Videos S4, S5 and
S6) or in the output CSV file data.
Analysis algorithms
We developed two analysis algorithms. The first determines the
average velocity of the moving contours inside each well. This
algorithm derives the velocity from the optical flow vectors of the
luminance component of the video stream from a pair of adjacent
frames approximately 100 ms apart. The algorithm uses the sparse
iterative version of the Lucas-Kanade optical flow in pyramids
provided with the OpenCV framework [29–31]. The set of pixels
to be considered when calculating the optical flow rate in the
current frame is limited in order to make the analysis
computationally feasible. This set of points is chosen at random
from the set of points that lie on the edge contours found within
the well using Canny’s algorithm (colored blue in Figure 2b and
5b). Some of these points will correspond to the well itself or other
artifacts, but these pixels will not possess a positive optical flow,
and will have no impact on the result, as the rate is only
determined based on the pixels which are determined to be
moving.
This algorithm is useful for scoring rates of motion (or lack
thereof) of single parasites with high accuracy as it can reliably
differentiate small differences in velocity which may correspond to
differing amounts of motility inhibition. A velocity in single
dimensional pixel units per second is reported. Only moving
components are considered, so this assay is not suitable for assays
Figure 2. Microtiter plate images and application real-time preview. (A) Video frames of 24-well plates of Brugia malayi were recorded using
the apparatus. (B) Screen capture of the software’s real-time preview user interface. Green circles indicate that the wells have been detected and that
the program is ready to begin recording data. The blue outline in each well is the worm (or other well artifacts) and the red color indicates the worm’s
movements. Mean movement units are measured in real-time and are shown for each well using the Lucas-Kanade Optical Flow algorithm. Canonical
well labels determined by the well finding algorithm are drawn in teal in the preview image by the application. (There is no movement in the 2 left
columns because the worms are dead due to high drug concentrations.)
doi:10.1371/journal.pntd.0001494.g002
WormAssay: Parasite Motion Screening Application
www.plosntds.org 4 January 2012 | Volume 6 | Issue 1 | e1494where a combination of dead (motionless) and moving parasites
are present in a single well, since only the moving parasites will be
considered in the score. This algorithm is described in WormAs-
say’s Options-Analyzer menu as ‘‘Lucas-Kanade Optical Flow.’’
The second algorithm is an algorithm that detects changes in
the occupation and vacancy of pixels between a group of frames. It
uses difference information between a subset of 5 frames chosen at
random from the frames that arrived in the past second. First, a
difference is performed on each of the 3 color channels of each of
the 5 frames and the current frame. Then high frequency
components are removed from each of the set of 5 difference
values. A voting scheme is employed to determine when a pixel
has had its contents changed. Three or more changed pixels is
deemed a quorum, otherwise the changes are ignored and deemed
noise. The number of filled or vacated pixels is then summed and
taken as a fraction of the total number of pixels within the well’s
circle (times 1000 to improve numerical readability). This number
is reported as an arbitrary area unit indicating motility. This
algorithm is useful for detecting very low levels of movement or for
quantifying the aggregate movement of more than one parasite in
a given well. This algorithm is described in the application as
‘‘Consensus Voting Luminance Difference.’’
All algorithms process in real-time, in parallel on each well. The
algorithm programming model is extensible; new algorithms can
be added independently of other components of the application.
To avoid recording spurious values when the plates are being
moved at the beginning or end of a run, the software ignores any
frames whose total motion (via the pixelwise mean of the simple
interframe absolute difference across all color channels) exceeds a
threshold. This value may need to be modified for assays with very
large or motile organisms. This is the only non-general threshold
used in the application. Improving this aberrant (whole plate)
motion detection is a possible area of further research.
Both algorithms (and the well detection) are computationally
intensive, and are not able to process every frame of the 1080p
(108061920 pixels) video input, which is typically 24 or 30 frames
per second. On a modern (2011) typical multicore desktop
computer, we are able to process 5–10 frames per second, which
yields satisfactory results. Since recording of all wells is done in
parallel, this is significantly faster than the 5–10 minute recoding
times necessary to generate even short 10 frames per second
movies on a well-by-well basis on commercial plate microscopes
(e.g. on the GE IN Cell Analyzer 2000.)
Dark-field macroscopic imaging apparatus
We also developed a dark-field parallel macroscopic imaging
apparatus connected to an HDV camera with an IEEE1394
interface using inexpensive materials [32] (Figure 1). The apparent
observable quality of the video recordings improves with greater
levels of contrast of the worm with the background. A dark-field
imaging scheme provides the most striking contrast, which gives
the computer application a greater level of signal-to-noise to
analyze. We found that a dark-field imaging scheme, where the
plates are illuminated from the side with a uniform light source (in
our case white LEDs) and a dark backdrop at least 5 cm from the
focus plane of the plate, provides ideal images for recording and
analysis. Due to the well finding mechanism, the plates must fill
Figure 3. Dose-response curves of anthelmintic compounds
used for validation. IC50s of (A) albendazole (236:2mM), (B)
ivermectin (2:7mM) and (C) fenbendazole (54:5mM) determined using
the proposed method with compounds at concentrations of 300mM,
100mM, 30mM, 10mM, 3mM and 0mM.
doi:10.1371/journal.pntd.0001494.g003
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considerable room for error.
The apparatus used consists of a light-tight box with a hinged lid
on the top, with the video camera mounted outside (to ensure easy
access and proper cooling) at the bottom of the box and recording
upwards. The whole box is made of plywood with some metal
parts, all painted black to minimize reflections. The plate is
positioned above the camera at such a distance that allows the
plate image to fully fill the field of view (approx. 35 cm). The plate
is illuminated by a dimmable white LED strip (Home Accent
Lighting Kit, White, PPA International) mounted parallel with the
plate walls at a distance of 25 mm.
The assay is very sensitive to inadvertent plate motion and
illumination that moves or is poor. Hence, it is important to shield
the recording field from ambient light so that the operator’s
movement does not cast a moving shadow on the field of view.
Figure 4. Simplified state machine of the plate detection and tracking logic. The nodes indicate distinct states (or the start/end
pseudostates) and the edges indicate transition conditions.
doi:10.1371/journal.pntd.0001494.g004
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One of the major stumbling blocks in identifying candidate
drugs for the treatment of lymphatic filariasis and river blindness is
the lack of a high throughput screening system for these large
worms. The filarid nematodes are long and threadlike and cannot
be easily assayed in a 96-well format. We therefore developed an
automated imaging system in which Brugia malayi could be assayed
in 24-well plates using a simple and inexpensive method called the
WormAssay.
The WormAssay is a visual imaging system that utilizes a novel
software program to capture video recordings to assay the effect of
compounds on macroparasites. To test the robustness of the
software program, we assayed Brugia malayi female worms with 3
antihelminthic drugs: albendazole and fenbendazole (benzimid-
azoles) and ivermectin (macrocyclic lactone). Albendazole is widely
used to treat intestinal nematode infections including ascariasisis
and hookworm; ivermectin is used in mass drug administration to
treat filariasis; and fenbendazole is used in the veterinary field to
treat animals infected with intestinal parasites. IC50 data using
these compounds with adult filarids are not available. However,
the study by Tompkins, Stitt and Ardelli (2010) showed that when
adult male and female Brugia malayi were exposed to ivermectin at
2:4mg=ml for 3 days, the motility (as measured in movements/
minute) decreased from 250 units to 125 units which is
approximately equivalent to the IC50 (2:7mM) in our study using
ivermectin (molecular weight=875.1 u) for 2 days [9]. Townson
et al. (1990) showed that adult male Onchocerca gutturosa exposed to
3:13mM of ivermectin in the course of 7 days had greatly reduced
motility levels (based on mean motility scores from 0–10)
compared to controls [13]. Motility scores for male worms
exposed to 50mM albendazole for 2 days were similar to those
for their control worms. Although Townson et al. used Onchocerca
adults in their study, their results for both albendazole and
ivermectin are consistent with our data.
We are currently using the visual imaging system to screen
approximately 400 adult Brugia females per assay. Along with our
visual imaging system, we use a Biomek FX (Beckman Coulter)
instrument to remove media from each well and dispense
compounds. It takes approximately 15 minutes per plate of 24
worms (1 worm/well) to screen compounds at a single concentra-
tion and approximately 20 minutes per plate for an IC50. The
system is capable of screening more worms but assay throughput is
currently limited by the number of worms produced and delivered.
Once we receive the 24-well plates containing individual adult
female Brugia, we estimate that it takes one person approximately
6–7 hours to setup an assay to screen 96 compounds (at single
concentrations) using the Biomek FX and run the WormAssay (on
Day 0). Plates are assessed every day for 3 days using the visual
imaging system which takes approximately 15–20 minutes for 16
plates. Control worms under these conditions remain highly active
while worms treated with low micromolar concentrations of
ivermectin are killed as evidenced by the lack of motility. We have
observed that the lack of motility is correlated with worm death;
dead worms appear more opaque (in some cases are slightly
tanned) and never regain motility.
Rather than using laborious and subjective methods of
analyzing plates (manual examination of individual wells and
plates with a dissecting scope and scoring worm movements
relative to control worms), the WormAssay quantified each worm’s
movement simultaneously on the entire plate, with each plate
taking approximately 30 seconds to 1 minute to read. Given the
short read times, researchers can increase the number of replicates
per compound, thus increasing the accuracy of the assay.
Currently, the system requires an individual to place the plate
into the visual imaging box but this system is amenable for use
with a robotic arm, removing and replacing plates to and from a
plate hotel. The software application also includes bar code
reading capabilities and can easily be exported to spreadsheets for
data analysis.
WormAssay is a unique high-throughput screening motility
assay that performs a parallel analysis on each well of entire plates
simultaneously, but is independent of specific plate geometry and
parasite morphology. The application supports 6-, 12-, 24-, 48-
and 96-well plates. WormAssay does not track specific organismal
characteristics so it can assay the motility of a large range of
macroscopic organisms that can be cultured in a microtiter plate,
but is capable of tracking very small or refined movements. The
assay requires commodity computer equipment and is compatible
with a variety of HD 1080p (or greater resolution) cameras and
video capture interfaces. This low-cost and simple-to-use system
can also be applied to other target organisms as well. Movements
of other macroparasites, including adult schistosome worms were
also assessed (see Figure 5), and studies with other macroorganisms
are currently being explored.
In summary, the WormAssay offers several advantages: 1) it is
inexpensive with costs of the video camera, LED lights and camera
totaling less than $3,000 USD and the software is freely available,
2) it is easy to use, i.e. the plate can be quickly placed into the box
housing the video camera and removed, 3) video recordings are
saved onto the computer along with the data and can be
reanalyzed at a later time, 4) entire plates with 6-, 12-, 24-, 48- and
Figure 5. Schistosoma mansoni adult worms can also be assayed
in 24- or 96-well plates using the WormAssay visual imaging
system. (A) Unprocessed video frame in a 96-well plate. (B) Screen
capture of the software’s user interface for those plates using the
Consensus Voting Luminance Difference algorithm (see caption for
Figure 2b).
doi:10.1371/journal.pntd.0001494.g005
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movement) is quantified and stored as CSV files and 6) can be
more generally applied to the study of macroparasites or other
macroscopic organisms.
Supporting Information
Video S1 Video recording generated from anthelmintic
assay for albendazole. The videos in supplements 1–3 may be
re-scored by using the application’s File–Open For Testing menu.
(MP4)
Video S2 Video recording generated from anthelmintic
assay for ivermectin.
(MP4)
Video S3 Video recording generated from anthelmintic
assay for fenbendazole.
(MP4)
Video S4 User interface recording generated from
anthelmintic assay for albendazole. Supplements 4–6 are
examples of the real-time user interface feedback provided by the
application using the videos from supplements 1–3. The high
frame drop rate observed is an artifact of the screen video
recording (for the purposes of generating this supplement) and did
not occur during the original data acquisition.
(MP4)
Video S5 User interface recording generated from
anthelmintic assay for ivermectin.
(MP4)
Video S6 User interface recording generated from
anthelmintic assay for fenbendazole.
(MP4)
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